Optinose is a biopharmaceutical company specializing in the development of unique therapeutics for patients with ear, nose, and throat conditions. The company's leading product, XHANCE, is designed for the treatment of chronic rhinosinusitis. Optinose is dedicated to addressing unmet medical needs through its innovative approaches. The focus is on expanding treatment options for patients suffering from CRS.